Vectorious Medical Technologies

Amit led a team of employees who developed, manufactured and sold a transcatheter cerebral embolic protection device for cardiac interventions. In Prior experiences Amit gained experience being a director of engineering and product manager. Eran is a seasoned entrepreneur and inventor in the medical devices industry, with a proven track record in establishing successful medical device companies, with products that are in use today. Weisz is an internationally recognized researcher focused on innovative technologies in cardiovascular medicine. Weisz serves as a reviewer for dozens of leading scientific journals and conferences. Weisz also serves on the editorial board of leading journals. Beyar currently serves as a General Partner at Alive Health Care Fund and is the co-founder of the ICI – Innovation in Cardiovascular Interventions, a leading international cardiovascular meeting. Beyar founded Instent (acquired by Medtronic), Corindus (Acquired by Siemens), Rambam MedTech and MindUp Incubator (together with IBM, Medtronic, Pitango & Impact First), and serves as director and advisor for several start-up companies.

Vascular Graft Solutions (VGS) was established in 2009, with the aim of improving the results ofcoronary revascularization procedures by developing innovative technologies.Using a research-driven approach, we have effectively addressed difficult and complex challenges in coronary revascularization, particularly vein graft disease in CABG surgery. Eyal is a serial MedTech entrepreneur and co-founder of multiple medical device companies. Eyal founded VGS in 2009 and served as CEO until October…. Orit is a veteran of the Israeli medical device industry with 25+ years of experience, fulfilling senior management roles in clinical, regulatory, research…. Tina is an expert in Global Medical Device Reimbursement with a focus on crafting payment structures for patient access, implementing reimbursement best practices to help hospitals and physicians maintain financial viability. Transitioning to VP operations and manufacturing, Liad successfully built and scaled VGS manufacturing process of the entire company’s portfolio to meet all quality and regulatory requirements, enabling market penetration and expansion. Orit is a veteran of the Israeli medical device industry with 25+ years of experience, fulfilling senior management roles in clinical, regulatory, research, and development. Eyal founded VGS in 2009 and served as CEO until October 2022.

Through our technology, we’re fulfilling our mission to alleviate heart failure symptoms, improve patient quality of life, and save lives. Eli is a mechanical engineer, inventor, and serial entrepreneur who is responsible for more than 100 inventions and 50 patents. Eli has more than 25 years of expertise in medical device development and interventional cardiology and has unique experience in developing cardiac metallic implants and delivery systems. Eli excels in leading product development teams from concept through product design and clinical approvals to worldwide sales. With rich expertise in clinical trial design and execution, Elad is skilled in business development in the field of medical devices, Good Clinical Practice (GCP), biomedical engineering, and cardiology. Dr Philip Lavin is a senior biomedical statistician and an independent statistical consultant for clinical trial design, analysis, execution, and representation to regulatory, reimbursement, and legal agencies. Dr Lavin has over 35 years serving as an expert consultant with core expertise in biostatistics. As a Managing Partner for Ballast Capital, Evan is on several MedTech boards and operates the investment firm, Ballast Capital LLC.

Ed is a named inventor on 30 granted patents and numerous patent applications. Rothman played a leading role in establishing interventional cardiology, particularly coronary angioplasty and stent implants. Rothman has founded and run a number of successful start-up companies and raised more than $1B in investment funding for early stage ventures. Henson has founded or served as CEO and chairman/board member for 18 emerging healthcare (medical device or biotechnology) firms. Neugarten has over 35 years of senior managerial experience, and over 15 years of experience in the medical industry. Thaler has more than 15 years of experience in investment management and financial research. Thaler is a board member of Vascular Dynamics, Ellipse Technologies, Interventional Spine, MiCardia, Tensys Medical and ValCare Medical. Vascular Dynamics is developing an innovative, endovascular platform technology to offer compelling treatment options for patients at risk of life-threatening conditions underserved by conventional treatments.

Filterlex receives the Best Innovation Award at the EuroPCR 2019 for the CAPTIS Embolic Protection Device for TAVI. Before joining Filterlex, Vered served as an RA Manager at Philips Medical Systems, and prior to that as a regulatory affairs consultant. Prior to joining Filterlex in 2018, Yoav served as R&D Manager at Nitiloop leading the design and development of the NovaCross™ micro-catheter for CTO treatment in the coronary and peripheral arteries. Eyal is a seasoned entrepreneur and CTO of several medical device start-ups. Eyal serves as the CTO of Sil Vascular and Cologuard and previously held senior R&D positions at Labcoat, Cappella, Talia Technology, Celtronix and Orbotech. An internationally recognized researcher focused on innovative technologies in cardiovascular medicine. Has been the Principal Investigator for pivotal clinical studies leading to FDA approval of cutting-edge technologies. Vered has over 14 years of experience in the medical device industry in several positions, including R&D, clinical, QA and regulatory affairs, spanning various types of products.

We are committed to providing sustainable, easy to use, medical grade digital solutions that help patients take control of their health. We believe that our customers’ needs always come first, so we strive to provide the most advanced technological solutions based on trust, business integrity and long-term commitment. Health care professionals trust us to deliver solutions and performance that enable them to do vital work for their patients. Our leadership team is dedicated to excellence in everything from solution development to patient experience, accountability, and fostering a spirit of daring and innovation. Cordio Medical’s Management leads a team of experts who apply a patient-centric approach to innovative solutions. In 1985, Ilan joined DSP and served as the Director of the Speech Processing Group and led a large team of engineers to develop and implement DSP’s speech recognition products worldwide. In 1993, Ilan founded NSC, a global company that developed and sold speech recognition products for telephony networks. In 2018, Itai joined Cordio Medical as VP R&D, leading and conducting algorithm research and development from POC to product.